SGLT-2 Inhibitors and Renal Outcomes in Non-Diabetic Patients: A Systematic Review
Introduction: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have shown positive renal outcomes in diabetic patients. There is also emerging evidence in non-diabetic patients. This review was conducted to analyse the renal outcomes of SGLT2i in patients without diabetes mellitus (DM). Methods: A...
Saved in:
Main Authors: | Mariana Silva de Sousa (Author), Cristiana Maia de Almeida (Author), Natália Marchão (Author), Iolanda Godinho (Author), José António Lopes (Author), Joana Gameiro (Author) |
---|---|
Format: | Book |
Published: |
Publicações Ciência e Vida,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research advances on renoprotective mechanism of SGLT-2 inhibitors in non-diabetic kidney disease
by: Feng Liu, et al.
Published: (2023) -
SGLT2 inhibitors and the changing landscape for treatment of diabetes
by: Liu S, et al.
Published: (2019) -
Retrospective analysis of the effect of SGLT-2 inhibitors on renal function in patients with type 2 diabetes in the real world
by: Rongjing Song, et al.
Published: (2024) -
Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus
by: Melpomeni Peppa, et al.
Published: (2023) -
Use of SGLT-2 Inhibitors in Patients With Type 1 Diabetes Mellitus
by: Lea El Hage MD, et al.
Published: (2019)